World Sleep Industry ENCYCLOPEDIA

Air-Pressure Therapy Devices

1.2.4

Medical definition and indication boundary

In a medical setting, an air-pressure therapy device generally means an intermittent pneumatic compression system. It combines an electric pump and controller, connecting tubes, and an inflatable garment. Repeated inflation and deflation applies external pressure to a foot, calf, thigh, arm or another specified region. Single-chamber, simultaneous multichamber and sequential segmented systems create different pressure patterns; the generic term “air pressure” does not define their function.

An exact model may be authorised for thrombosis prevention in selected patients, venous or lymphatic insufficiency, oedema, a defined wound or postoperative management, or for only one of these uses. The indication belongs to the matched controller, garment, labelling and clinical protocol and cannot be transferred between models. Consumer recovery boots and massage sleeves cannot borrow the evidence or medical claims of an IPC system.

System components and pressure performance

Essential performance includes chamber count and overlap, anatomical coverage, pressure range and accuracy, gradients between chambers, inflation sequence, rate of pressure rise, hold and release times, cycle period, repeatability, blocked-tube or leak alarms, release after power loss and timing. A controller display is meaningful only with the matched garment and stated test conditions. Perceived intensity cannot replace performance verification.

The controller, tubes, connectors and garment form one system. A sleeve with a different length, chamber volume or connector changes the inflation curve and pressure distribution even when it can be attached physically. A unit with individually adjustable chambers also needs documentation of any disabled region and the reason. If heat, cold or a wound-care accessory is integrated, each function requires separate acceptance and risk control.

Patient assessment and prescribed plan

Before treatment, establish the diagnosis, objective, treatment site and outcome measures. Record limb circumference, characteristics of swelling, skin integrity, wounds, pain, sensation, colour, temperature and distal perfusion. Lymphatic oedema, venous oedema, swelling caused by cardiac, renal or hepatic disease, thrombosis, infection and other causes can appear similar without being equally suitable for compression.

The plan should specify the exact controller and garment, pressure, programme, session duration, frequency, position, coordination with bandaging or compression garments, review date and stop criteria. For home use, confirm that the user or caregiver can fit the garment, inspect skin, use emergency release, clean the system and document the response. Pneumatic compression is commonly one part of management and does not automatically replace exercise, elevation, skin care, wound management or other prescribed treatment.

Setup, fitting and treatment monitoring

Measure the limb at the stated landmarks and select the correct garment. Smooth the lining and chambers and keep wrinkles, overlap, thick clothing seams, clinical tubing and foreign objects away from the skin. Air hoses must not kink, become compressed or create a trip hazard. Confirm that the controller and quick release are accessible. A trained person should observe a complete first cycle and any session after a parameter change.

During treatment, monitor pain, sensation, skin colour and temperature, distal perfusion, wound dressings and garment edges. A material change in oedema requires remeasurement rather than continued use of the old size. A patient must not walk in an inflated garment or undergo treatment without monitoring when unable to release it independently. Stop the pump and allow complete deflation before slow removal, inspect the skin, and record parameters, tolerance and objective change.

Contraindications, complications and urgent response

Known or suspected DVT or pulmonary embolism, acute thrombophlebitis, severe ischaemic or peripheral arterial disease, decompensated heart failure, pulmonary oedema, acute infection or cellulitis, massive oedema, an open or unprotected wound, recent skin graft, fragile skin or severe sensory loss requires model-specific professional assessment before use. Active cancer treatment, organ failure or recent surgery can also change the risk and plan.

New unilateral swelling, pain, warmth, redness or discoloration needs prompt assessment for thrombosis. Sudden breathlessness, chest pain with breathing, coughing blood, an abnormal heartbeat, lightheadedness or fainting requires emergency help. Severe pain, numbness, pale or blue digits, blistering, bleeding, increased wound drainage, sustained excessive pressure or inability to deflate during treatment requires immediate stopping and pressure release, followed by clinical assessment and equipment quarantine as appropriate.

Outcome evaluation and claim boundary

Outcomes should match the original objective, such as change in circumference or volume, tissue character, symptoms, skin status, wound progress, function or adherence to a thromboprophylaxis plan, and be recorded under comparable conditions. A softer limb or reduced circumference after one session may reflect temporary fluid movement and does not independently demonstrate reversal of disease. Subjective lightness cannot replace longitudinal outcomes and safety monitoring.

Evidence for different diseases, garments and programmes is not interchangeable. A lymphoedema protocol is not a DVT-prevention protocol, and a medical thromboprophylaxis device is not automatically suitable for undiagnosed swelling. IPC cannot detoxify, dissolve an existing clot, permanently cure varicose veins, or replace anticoagulation, wound care or specialist lymphatic therapy. Failure to meet the objective calls for reassessment of diagnosis, fit and the overall plan rather than unsupervised pressure escalation.

Cleaning, maintenance and quality records

Clean skin-contact surfaces and removable liners as instructed and dry them fully before use. Wound care and shared equipment require a material-compatible infection-control process that keeps drainage out of chamber valves, tubing and the pump. Do not immerse the controller or treat garments with corrosive solvents. Residual cleaner, moisture and textile damage can affect both skin and pressure performance.

Scheduled checks should cover chamber leaks or bulging, seams and straps, connectors and tubing, filters, pump noise, measured pressure, cycle timing, alarms, power-loss deflation and electrical safety. Reconfirm system performance after repair or component replacement. The prescription, baseline measurements, controller and garment identifiers, session settings, skin observations, outcomes, adverse events and maintenance history together create traceable medical use; operating time alone does not.